Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb.

Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R.

Trends Pharmacol Sci. 2009 Oct;30(10):515-27. doi: 10.1016/j.tips.2009.07.006. Epub 2009 Sep 2. Review. Erratum in: Trends Pharmacol Sci. 2009 Dec;30(12):609.

PMID:
19729208
2.

Cannabinoids for gastrointestinal diseases: potential therapeutic applications.

Di Carlo G, Izzo AA.

Expert Opin Investig Drugs. 2003 Jan;12(1):39-49. Review.

PMID:
12517253
3.

Therapeutic potential of cannabinoids in CNS disease.

Croxford JL.

CNS Drugs. 2003;17(3):179-202. Review.

PMID:
12617697
4.

Phytocannabinoids as novel therapeutic agents in CNS disorders.

Hill AJ, Williams CM, Whalley BJ, Stephens GJ.

Pharmacol Ther. 2012 Jan;133(1):79-97. doi: 10.1016/j.pharmthera.2011.09.002. Epub 2011 Sep 6. Review.

PMID:
21924288
5.

CB receptor ligands from plants.

Woelkart K, Salo-Ahen OM, Bauer R.

Curr Top Med Chem. 2008;8(3):173-86. Review.

PMID:
18289087
6.
7.

Cannabis and the brain.

Iversen L.

Brain. 2003 Jun;126(Pt 6):1252-70. Review.

PMID:
12764049
8.

Therapeutic potential of cannabis in pain medicine.

Hosking RD, Zajicek JP.

Br J Anaesth. 2008 Jul;101(1):59-68. doi: 10.1093/bja/aen119. Epub 2008 May 29. Review.

PMID:
18515270
9.

Pharmacology of cannabinoids.

Grotenhermen F.

Neuro Endocrinol Lett. 2004 Feb-Apr;25(1-2):14-23. Review.

PMID:
15159677
10.

Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?

Oesch S, Gertsch J.

J Pharm Pharmacol. 2009 Jul;61(7):839-53. doi: 10.1211/jpp/61.07.0002. Review.

PMID:
19589225
11.

Phytocannabinoids and endocannabinoids.

Fisar Z.

Curr Drug Abuse Rev. 2009 Jan;2(1):51-75. Review.

PMID:
19630737
12.

Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects.

Roser P, Gallinat J, Weinberg G, Juckel G, Gorynia I, Stadelmann AM.

Eur Arch Psychiatry Clin Neurosci. 2009 Aug;259(5):284-92. doi: 10.1007/s00406-009-0868-5. Epub 2009 Feb 17.

PMID:
19224107
14.

Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy.

Rice AS, Farquhar-Smith WP, Nagy I.

Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):243-56. Review.

PMID:
12052040
15.

[Therapeutic applications and biomedical effects of cannabinoids; pharmacological starting points].

Killestein J, Nelemans SA.

Ned Tijdschr Geneeskd. 1997 Aug 30;141(35):1689-93. Review. Dutch.

PMID:
9543785
16.

Cannabinoids in clinical practice.

Williamson EM, Evans FJ.

Drugs. 2000 Dec;60(6):1303-14. Review.

PMID:
11152013
17.

Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes.

Di Marzo V, Piscitelli F, Mechoulam R.

Handb Exp Pharmacol. 2011;(203):75-104. doi: 10.1007/978-3-642-17214-4_4. Review.

PMID:
21484568
18.

Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.

Burns TL, Ineck JR.

Ann Pharmacother. 2006 Feb;40(2):251-60. Epub 2006 Jan 31. Review.

PMID:
16449552
19.

The neurobiology and evolution of cannabinoid signalling.

Elphick MR, Egertov√° M.

Philos Trans R Soc Lond B Biol Sci. 2001 Mar 29;356(1407):381-408. Review.

20.

Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids.

Hanus LO.

Med Res Rev. 2009 Mar;29(2):213-71. doi: 10.1002/med.20135. Review.

PMID:
18777572

Supplemental Content

Support Center